Impact of radiotherapy modalities on local control and survival in adjuvant breast cancer treatment;Prise en charge adjuvante des cancers invasifs du sein : les techniques de radiothérapie modifient-elles les taux de contrôle local et de survie ?

Cancer/Radiotherapie

Volumn 13, Issue 5, 2009, Pages 434-445

  Azria, D ^a   Hennequin, C ^b  

^a CENTRE VAL D AURELLE   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Breast cancer; Local control; Radiotherapy; Survival; Techniques

Indexed keywords

LETROZOLE;

BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL EVALUATION; CLINICAL RESEARCH; DESQUAMATION; HEART; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTRAOPERATIVE RADIOTHERAPY; LUNG; MASTECTOMY; MODULATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION PROTECTION; RIB; RISK FACTOR; SHORT SURVEY; THERAPY EFFECT; THORAX;

APOPTOSIS; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CD8-POSITIVE T-LYMPHOCYTES; DOSE FRACTIONATION; FEMALE; HUMANS; LYMPHATIC IRRADIATION; MASTECTOMY; RADIATION TOLERANCE; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, CONFORMAL; RESPIRATION; TUMOR BURDEN;

EID: 68749102004     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canrad.2009.01.006     Document Type: Short Survey

References (83)

1. Antonucci JV, Wallace M, Goldstein NS, Kestin L, Chen P, Benitez P, et al. Differences in patterns of failure in patients treated with accelerated partial breast irradiation versus whole-breast irradiation: a matched-pair analysis with 10-year follow-up. Int J Radiat Oncol Biol Phys 2008, in press.
2. Azria D., Belkacemi Y., Lagrange J.L., Chapet O., Mornex F., Maingon P., et al. Séquelles radio-induites et tests prédictifs. Cancer Radiother 12 (2008) 619-624
3. Azria D., Gourgou S., Sozzi W.J., Zouhair A., Mirimanoff R.O., Kramar A., et al. Concomitant use of tamoxifen with radiotherapy enhances subcutaneous breast fibrosis in hypersensitive patients. Br J Cancer 91 (2004) 1251-1260
4. Azria D., Ozsahin M., Kramar A., Peters S., Atencio D.P., Crompton N.E., et al. Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 14 (2008) 6284-6288
5. Barendsen GW. RBE as a function of dose for effects on tissues and tumors assessed by the linear-quadratic model. Int J Radiat Oncol Biol Phys 2000;46:684-5.
6. Bartelink H., Horiot J.C., Poortmans P., Struikmans H., Van den Bogaert W., Barillot I., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345 (2001) 1378-1387
7. Bartelink H., Horiot J.C., Poortmans P.M., Struikmans H., Van den Bogaert W., Fourquet A., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
8. Belkacemi Y., and Azria D. Innovations en radiothérapie adjuvante du cancer du sein. Bull Cancer 94 (2007) 389-397
9. Belkacemi Y., Chauvet M.P., Giard S., Villette S., Lacornerie T., Bonodeau F., et al. Partial breast irradiation as sole therapy for low risk breast carcinoma: early toxicity, cosmesis and quality of life results of a MammoSite brachytherapy phase II study. Radiother Oncol 90 (2009) 23-29
10. Belkacemi Y., Comet B., Hannoun-Levi J.M., Villette S., Marsiglia H., Leblanc-Onfroy M., et al. Irradiation partielle et accélérée du sein : un concept pour une individualisation thérapeutique dans le cancer du sein. Cancer Radiother 11 (2007) 287-295
11. Belkacemi Y., Villette S., Chauvet M., Olszyk O., Giard S., Lacornerie T., et al. Irradiation partielle per- et périopératoire du sein : rationnel et description des techniques. Ref Gynecol obstet 11 (2005) 153-158
12. Bentzen S.M., Agrawal R.K., Aird E.G., Barrett J.M., Barrett-Lee P.J., Bentzen S.M., et al. The UK standardisation of breast radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet 371 (2008) 1098-1107
13. Bentzen S.M., Agrawal R.K., Aird E.G., Barrett J.M., Barrett-Lee P.J., Bliss J.M., et al. The UK standardisation of breast radiotherapy (START) trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial. Lancet Oncol 9 (2008) 331-341
14. Bernier J., Viale G., Orecchia P., Ballardini B., Richetti A., Bronz L., et al. Partial irradiation of the breast: old challenges, new solutions. The Breast 15 (2006) 466-475
15. Borger J.H., Hooning M.J., Boersma L.J., Snijders-Keilholz A., Aleman B.M., Lintzen E., et al. Cardiotoxic effects of tangential breast irradiation in early breast cancer patients: the role of irradiated heart volume. Int J Radiat Oncol Biol Phys 69 (2007) 1131-1138
16. Coen J.J., Taghian A.G., Kachnic L.A., Assaad S.I., and Powell S.N. Risk of lymphedema after regional nodal irradiation with breast conservation therapy. Int J Radiat Oncol Biol Phys 55 (2003) 1209-1215
17. Crompton N.E., and Ozsahin M. A versatile and rapid assay of radiosensitivity of peripheral blood leukocytes based on DNA and surface-marker assessment of cytotoxicity. Radiat Res 147 (1997) 55-60
18. Crompton N.E., Shi Y.Q., Emery G.C., Wisser L., Blattmann H., Maier A., et al. Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 49 (2001) 547-554
19. Deng G., Lu Y., and Zlotnikov G. Loss of heterozygosity in normal tissue adjacent to breast carcinomas. Science 274 (1996) 2057-2059
20. Dewey W.C., Ling C.C., and Meyn R.E. Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys 33 (1995) 781-796
21. Dubray B., Delanian S., and Lefaix J.L. Effets tardifs de la radiothérapie mammaire sur la peau et les tissus sous-cutanés. Cancer Radiother 1 (1997) 744-752
22. Edmundson G.K., Vicini F.A., Chen P.Y., Mitchell C., and Martinez A.A. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 52 (2002) 1132-1139
23. Emami B., Lyman J., Brown A., Coia L., Goitein M., Munzenrider J.E., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
24. Fernet M., and Hall J. Predictive markers for normal tissue reactions: fantasy or reality?. Cancer Radiother 12 (2008) 614-618
25. Floyd D.N., and Cassoni A.M. Intrinsic radiosensitivity of adult and cord blood lymphocytes as determined by the micronucleus assay. Eur J Cancer 30 (1994) 615-620
26. Ford E.C., Mageras G.S., Yorke E., Rosenzweig K.E., Wagman R., and Ling C.C. Evaluation of respiratory movement during gated radiotherapy using film and electronic portal imaging. Int J Radiat Oncol Biol Phys 52 (2002) 522-531
27. Fourquet A., Kirova Y., Bollet M.A., Tournat H., Dendale R., and Campana F. Méta-analyses des effets de la radiothérapie dans le cancer du sein : la preuve absolue ?. Cancer Radiother 12 (2008) 554-558
28. Frazier R.C., Vicini F.A., Sharpe M.B., Yan D., Fayad J., Baglan K.L., et al. Impact of breathing motion on whole breast radiotherapy: a dosimetric analysis using active breathing control. Int J Radiat Oncol Biol Phys 58 (2004) 1041-1047
29. Freedman G.M., Anderson P.R., Li J., Eisenberg D.F., Hanlon A.L., Wang L., et al. Intensity modulated radiation therapy (IMRT) decreases acute skin toxicity for women receiving radiation for breast cancer. Am J Clin Oncol 29 (2006) 66-70
30. Fuller S.A., Haybittle J.L., Smith R.E., and Dobbs H.J. Cardiac doses in postoperative breast irradiation. Radiother Oncol 25 (1992) 19-24
31. Giraud P., Simon L., and Saliou M. La radiothérapie asservie à la respiration : la radiothérapie 4D. Bull Cancer 92 (2005) 83-89
32. Gyenes G. Radiation-induced ischemic heart disease in breast cancer-a review. Acta Oncol 37 (1998) 241-246
33. Gyenes G. In regards to Marks et al. on radiation therapy-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63 (2005) 214-223
34. Gyenes G., Gagliardi G., Lax I., Fornander T., and Rutqvist L.E. Evaluation of irradiated heart volumes in stage I breast cancer patients treated with postoperative adjuvant radiotherapy. J Clin Oncol 15 (1997) 1348-1353
35. Hennequin C., Romestaing P., and Maylin C. Irradiation des aires ganglionnaires dans le cancer du sein. Cancer Radiother 12 (2008) 559-564
36. Hennequin et al. Le traitement conservateur du cancer du sein. In: Marc Espié et André Gorins, éditeurs. Le sein : du normal au pathologique : état de l'art. Éditions ESKA;2007.
37. Ho A.Y., Atencio D.P., Peters S., Stock R.G., Formenti S.C., Cesaretti J.A., et al. Genetic predictors of adverse radiotherapy effects: the Gene-PARE project. Int J Radiat Oncol Biol Phys 65 (2006) 646-655
38. Hoeller U., Borgmann K., Bonacker M., Kuhlmey A., Bajrovic A., Jung H., et al. Individual radiosensitivity measured with lymphocytes may be used to predict the risk of fibrosis after radiotherapy for breast cancer. Radiother Oncol 69 (2003) 137-144
39. Hojris I., Overgaard M., Christensen J.J., and Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 354 (1999) 1425-1430
40. Hurkmans C.W., Saarnak A.E., Pieters B.R., Borger J.H., and Bruinvis I.A. An improved technique for breast cancer irradiation including the locoregional lymph nodes. Int J Radiat Oncol Biol Phys 47 (2000) 1421-1429
41. Johansen J., Bentzen S.M., Overgaard J., and Overgaard M. Relationship between the in vitro radiosensitivity of skin fibroblasts and the expression of subcutaneous fibrosis, telangiectasia, and skin erythema after radiotherapy. Radiother Oncol 40 (1996) 101-109
42. Keall P.J., Joshi S., Vedam S.S., Siebers J.V., Kini V.R., and Mohan R. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys 32 (2005) 942-951
43. Kiltie A.E., Ryan A.J., Swindell R., Barber J.B., West C.M., Magee B., et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol 51 (1999) 55-65
44. Krauss D.J., Kestin L.L., Raff G., Yan D., Wong J., Gentry R., et al. MRI-based volumetric assessment of cardiac anatomy and dose reduction via active breathing control during irradiation for left-sided breast cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1243-1250
45. Lartigau E., Dubray B., and Mornex F. Mécanismes biologiques des effets tardifs des radiations ionisantes. Cancer Radiother 1 (1997) 669-676
46. Lemanski C, Azria D, Gourgou S, Gutowski M, Rouanet P, Saint Aubert B, et al. Intraoperative radiotherapy in early-stage breast cancer: results of the Montpellier phase II trial. Int J Radiat Oncol Biol Phys 2009, in press.
47. Lemanski C., Azria D., Thezenas S., Gutowski M., Saint-Aubert B., Rouanet P., et al. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results. Int J Radiat Oncol Biol Phys 64 (2006) 1410-1415
48. Marks L.B., Yu X., Prosnitz R.G., Zhou S.M., Hardenbergh P.H., Blazing M., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63 (2005) 214-223
49. Merrick III H.W., Hager E., and Dobelbower Jr. R.R. Intraopertive radiation therapy for breast cancer. Surg Oncol Clin N Am 12 (2003) 1065-1078
50. Overgaard M., Hansen P.S., Overgaard J., Rose C., Andersson M., Bach F., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
51. Overgaard M., Jensen M.B., Overgaard J., Hansen P.S., Rose C., Andersson M., et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 353 (1999) 1641-1648
52. Owen J.R., Ashton A., Bliss J.M., Homewood J., Harper C., Hanson J., et al. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: long-term results of a randomised trial. Lancet Oncol 7 (2006) 467-471
53. Ozsahin M., Crompton N.E., Gourgou S., Kramar A., Li L., Shi Y., et al. CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11 (2005) 7426-7433
54. Ozsahin M., Ozsahin H., Shi Y., Larsson B., Wurgler F.E., and Crompton N.E. Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 38 (1997) 429-440
55. Park C.C., Mitsumori M., Nixon A., Recht A., Connolly J., and Gelman R. Outcome at 8 years after breast-conserving surgery and radiation therapy for invasive breast cancer: influence of margin status and systemic therapy on local recurrence. J Clin Oncol 18 (2000) 1668-1675
56. Pignol J.P., Olivotto I., Rakovitch E., Gardner S., Sixel K., Beckham W., et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol 26 (2008) 2085-2092
57. Polgar C., Fodor J., Orosz Z., Major T., Takacsi-Nagy Z., Mangel L.C., et al. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial. Strahlenther Onkol 178 (2002) 615-623
58. Polgar C., Major T., and Fodor J. High-dose-rate brachytherapy alone versus whole breast radiotherapy with or without tumor bed boost after breast-conserving surgery: seven-year results of a comparative study. Int J Radiat Oncol Biol Phys 60 (2004) 1173-1181
59. Poortmans P.M. Elective radiotherapy of the regional lymph node areas in breast cancer. Cancer Radiother 10 (2006) 343-348
60. Poortmans P.M., Collette L., Bartelink H., Struikmans H., Van den Bogaert W.F., Fourquet A., et al. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer. A summary of the results of EORTC 22881-10882 "boost versus no boost" trial. Cancer Radiother 12 (2008) 565-570
61. Potters L., Steinberg M., Wallner P., and Hevezi J. How one defines intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 56 (2003) 609-610
62. Radford I.R., and Murphy T.K. Radiation response of mouse lymphoid and myeloid cell lines. Part III. Different signals can lead to apoptosis and may influence sensitivity to killing by DNA double-strand breakage. Int J Radiat Biol 65 (1994) 229-239
63. Reitsamer R., Peintinger F., Kopp M., Menzel C., Kogelnik H.D., and Sedlmayer F. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study. Strahlenther Onkol 180 (2004) 38-44
64. Ribeiro G.G., Dunn G., Swindell R., Harris M., and Banerjee S.S. Conservation of the breast using two different radiotherapy techniques: interim report of a clinical trial. Clin Oncol (R Coll Radiol) 2 (1990) 27-34
65. Ribeiro G.G., Magee B., Swindell R., Harris M., and Banerjee S.S. The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5 (1993) 278-283
66. Romestaing P., Lehingue Y., Carrie C., Coquard R., Montbarbon X., Ardiet J.M., et al. Role of a 10-Gy boost in the conservative treatment of early breast cancer: results of a randomized clinical trial in Lyon, France. J Clin Oncol 15 (1997) 963-968
67. Slonina D., and Gasinska A. Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol 72 (1997) 693-701
68. Smith T.E., Lee D., Turner B.C., Carter D., and Haffty B.G. True recurrence versus new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48 (2000) 1281-1289
69. Strom E.A., Woodward W.A., Katz A., Buchholz T.A., Perkins G.H., Jhingran A., et al. Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy. Int J Radiat Oncol Biol Phys 63 (2005) 1508-1513
70. Suami H., Pan W.R., Mann G.B., and Taylor G.I. The lymphatic anatomy of the breast and its implications for sentinel lymph node biopsy: a human cadaver study. Ann Surg Oncol 15 (2008) 863-871
71. Taghian A., Jeong J.H., Mamounas E., Anderson S., Bryant J., Deutsch M., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 (2004) 4247-4254
72. Taghian A.G., Kozak K.R., Doppke K.P., Katz A., Smith B.L., Gadd M., et al. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial-breast irradiation. Int J Radiat Oncol Biol Phys 64 (2006) 1092-1099
73. Trowell O.A. The sensitivity of lymphocytes to ionising radiation. J Pathol Bacteriol 64 (1952) 687-704
74. Van Limbergen E. Indications and technical aspects of brachytherapy in breast conserving treatment of breast cancer. Cancer Radiother 7 (2003) 107-120
75. Veronesi U., Marubini E., Mariani L., Galimberti V., Luini A., Veronesi P., et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 12 (2001) 997-1003
76. Vicini F., Beitsch P.D., Quiet C.A., Keleher A.J., Garcia D., Snider Jr. H.C., et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer 112 (2008) 758-766
77. Vicini F., Sharpe M., Kestin L., Wong J., Remouchamps V., and Martinez A. The use of intensity modulated radiation therapy in the treatment of breast cancer: evolving definition, misdirected criticism, and untoward effects. Int J Radiat Oncol Biol Phys 58 (2004) 1642-1644
78. Vicini F.A., Beitsch P.D., Quiet C.A., Keleher A., Garcia D., Snider H.C., et al. First analysis of patient demographics, technical reproducibility, cosmesis, and early toxicity: results of the American Society of Breast Surgeons MammoSite breast brachytherapy trial. Cancer 104 (2005) 1138-1148
79. Vicini F.A., Kestin L., Chen P., Benitez P., Goldstein N.S., and Martinez A. Limited-field radiation therapy in the management of early-stage breast cancer. J Natl Cancer Inst 95 (2003) 1205-1210
80. Weed D.W., Edmundson G.K., Vicini F.A., Chen P.Y., and Martinez A.A. Accelerated partial breast irradiation: a dosimetric comparison of three different techniques. Brachytherapy 4 (2005) 121-129
81. Whelan T., MacKenzie R., Julian J., Levine M., Shelley W., Grimard L., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
82. Yarnold J., Ashton A., Bliss J., Homewood J., Harper C., Hanson J., et al. Fractionation sensitivity and dose response of late adverse effects in the breast after radiotherapy for early breast cancer: long-term results of a randomised trial. Radiother Oncol 75 (2005) 9-17
83. Yu J., Li G., Li J., and Wang Y. The pattern of lymphatic metastasis of breast cancer and its influence on the delineation of radiation fields. Int J Radiat Oncol Biol Phys 61 (2005) 874-878